Twist Bioscience (TWST) Share-based Compensation (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Share-based Compensation data on file, last reported at $18.9 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $18.9 million, down 6.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.3 million (up 10.19% YoY), and the FY2025 annual result was $64.5 million, up 26.58% from the prior year.
• Share-based Compensation climbed to $18.9 million in Q1 2026 per TWST's latest filing, from $13.3 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $22.5 million in Q1 2022 and troughed at -$2.3 million in Q4 2022.
• A 5-year average of $14.1 million and a median of $13.7 million in 2024 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation sank 112.84% in 2022, then soared 573.98% in 2023.
• A 5-year view of Share-based Compensation shows it stood at -$2.3 million in 2022, then soared by 573.98% to $11.0 million in 2023, then gained by 8.81% to $12.0 million in 2024, then climbed by 10.69% to $13.3 million in 2025, then surged by 42.67% to $18.9 million in 2026.
• Business Quant data shows TWST's Share-based Compensation at $18.9 million in Q1 2026, $13.3 million in Q4 2025, and $16.1 million in Q3 2025.